Treatment of essential hypertension uncontrolled by monotherapy in adults and in children and adolescents 6-18 years of age.
Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of an antihypertensive treatment).
Treatment of chronic heart failure in adult patients when treatment with Angiotensin converting enzyme (ACE) inhibitors is not considered suitable due to incompatibility, especially cough, or contraindication
Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG
